In a recent study, abemaciclib demonstrated clinical activity both alone and in combinations in women with HR+ metastatic breast cancer.
Jenny Powers, PhD
Articles by Jenny Powers, PhD
Latest Updated Articles
Abemaciclib Combinations Demonstrate Long-Term Disease Control in HR+ Breast CancerPublished: October 19th 2016 | Updated: